Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen and nitrogen species (RONS) are a diverse group of highly reactive, oxygen- and nitrogen-containing molecules that include both free radicals, such as superoxide and nitric oxide, and non-radical oxidants like hydrogen peroxide and peroxynitrite [3, 11]. They are primarily generated as byproducts of mitochondrial aerobic metabolism and by specialized enzymes like NADPH oxidases during the immune system's oxidative burst [4, 10]. At physiological levels, RONS serve as essential secondary messengers in redox signaling pathways that regulate cell proliferation, differentiation, and apoptosis [2, 11]. However, an imbalance between RONS production and the body's antioxidant defense mechanisms leads to oxidative and nitrosative stress, causing irreversible damage to DNA, proteins, and lipids [1, 6]. This molecular damage is a key driver in the pathogenesis of various conditions, including neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), cardiovascular disorders, and cancer [5, 11]. Therapeutic interventions focus on neutralizing these species using radical scavengers like Edaravone, which inhibits lipid peroxidation and protects cellular membranes, or by supplementing endogenous antioxidant systems with agents like N-acetylcysteine [5, 7, 13].
Drugs targeting these species primarily act through direct free radical scavenging, neutralization of non-radical oxidants, inhibition of lipid peroxidation, and the upregulation of endogenous antioxidant enzymes to restore redox balance [5, 7, 12].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen and nitrogen species (RONS) (RONS).